According to IMARC Group’s latest report, titled “China Genetic Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.’ the China genetic testing market size reached US$ 3.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.2 Billion by 2028, exhibiting a growth rate (CAGR) of 16.2% during 2023-2028.

Genetic testing is a medical test that analyzes an individual's DNA to identify changes or mutations in their genetic code that could lead to or cause a particular disease or condition. It can also be used to determine an individual's risk of developing certain conditions or to confirm a diagnosis in individuals with symptoms or a family history of a particular disease. Genetic testing can be done using various methods, such as blood samples, saliva samples, or tissue biopsies. The results of genetic testing can provide valuable information about an individual's health and help guide medical decisions, including treatment options, disease management, and family planning.

Request for a PDF Sample of this Report: https://www.imarcgroup.com/china-genetic-testing-market/requestsample

China Genetic testing Market Trends:

The rising awareness regarding the benefits of genetic testing, including the ability to identify genetic risks for diseases and to make informed decisions about medical treatment and family planning represents a significant factor driving the market growth across the country. In line with this, the increasing prevalence of genetic disorders and chronic diseases in China, along with the increasing geriatric population, lifestyle changes, and environmental factors are contributing to the growth of the market. In addition to this, the Government of People’s Republic of China (PRC) has been actively promoting the development of the biotechnology industry, which is another factor inducing the market growth. Other factors, such as extensive research and development (R&D) activities and significant technological advancements, are creating a positive outlook for the market across the country.

China Genetic testing Market 2023-2028 Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

The competitive landscape of the China genetic testing market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

• BGI
• Berry Genomics Co. ltd.
• Daan Gene Co. Ltd
• WuXi NextCODE
• Annoroad Gene Technology Co. Ltd.
• WuXi PharmaTech

Key Market Segmentation:

The report has segmented the China genetic testing market on the basis of test type, disease, technology, service provider and testing sample.

Breakup by Test Type:

• Prenatal Testing
• Carrier Testing
• New Born Testing
• Predictive/Presymptomatic Testing
• Diagnostic Testing
• Others

Breakup by Disease:

• Cancer
• Down Syndrome
• Thalassemia
• Others

Breakup by Technology:

• Biochemical
• Molecular
• Cytogenetic

Breakup by Service Provider:

• Hospital Based Laboratories
• Independent Laboratories
• Specialty Clinics

Breakup by Testing Sample:

• Blood
• Saliva
• Hair
• Others

Ask Analyst for Customization and Explore full Report with TOC & List of Figures: https://www.imarcgroup.com/request?type=reportid=1111flag=F

Key Highlights of the Report:                                                           

• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:                                                                    

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact:

IMARC Group
134 N 4th St
Brooklyn, NY 11249, USA
Email: [email protected]
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800